Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Clinical Study of Effects of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension

NCT01637675 is registered in ClinicalTrials.gov with The First Affiliated Hospital of Guangzhou Medical University as lead sponsor.

NCT NCT01637675
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01637675 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Clinical Study of Effects of Sodium Tanshinone IIA Sulfonate on Pulmonary Hypertension
Lead sponsor
The First Affiliated Hospital of Guangzhou Medical University
Phase
Phase 2/3
Overall status
Unknown status
Start date
May 31, 2013
Completion date
December 31, 2014
Enrollment
90 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cardiovascular diseases, lung diseases, pulmonary arterial hypertension, pulmonary hypertension, tanshinone iia sulfonate